Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-02-28

FDA Approved: LEVETIRACETAM — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' original ANDA for levetiracetam oral, authorizing a generic version of the antiepileptic drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM ORAL (levetiracetam)

Snippet

ORIG AP for LEVETIRACETAM (LEVETIRACETAM ORAL)